02.09.2015 Views

Fatty liver disease - Virtual Pathology at the University of Leeds

Fatty liver disease - Virtual Pathology at the University of Leeds

Fatty liver disease - Virtual Pathology at the University of Leeds

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Basic p<strong>at</strong>terns <strong>of</strong> <strong>liver</strong> damage – wh<strong>at</strong><br />

inform<strong>at</strong>ion can a <strong>liver</strong> biopsy provide<br />

and wh<strong>at</strong> clinical inform<strong>at</strong>ion does <strong>the</strong><br />

p<strong>at</strong>hologist need?<br />

Rob Goldin<br />

r.goldin@imperial.ac.uk


Wh<strong>at</strong> inform<strong>at</strong>ion can a <strong>liver</strong><br />

biopsy provide?


Donald Rumsfeld’s guide to knowledge<br />

(and to <strong>liver</strong> biopsy requests)<br />

• “… <strong>the</strong>re are known knowns; <strong>the</strong>re are things<br />

we know we know.<br />

• We also know <strong>the</strong>re are known unknowns;<br />

th<strong>at</strong> is to say we know <strong>the</strong>re are some things<br />

we do not know.<br />

• But <strong>the</strong>re are also unknown unknowns - <strong>the</strong><br />

ones we don't know we don't know."


“….<strong>the</strong>re are known knowns; <strong>the</strong>re<br />

are things we know we know.”


The clinician knows <strong>the</strong> diagnosis but<br />

wants to know something more<br />

Examples<br />

1. Chronic viral hep<strong>at</strong>itis<br />

2. <strong>F<strong>at</strong>ty</strong> <strong>liver</strong> <strong>disease</strong><br />

3. Iron overload


Chronic viral hep<strong>at</strong>itis<br />

• Assess <strong>disease</strong> severity:<br />

Grade (necro-inflamm<strong>at</strong>ion) and<br />

Stage (fibrosis)<br />

? Score (using modified Histological Activity<br />

Index / METAVIR)<br />

• Assess <strong>disease</strong> progression or response to<br />

tre<strong>at</strong>ment<br />

Modern <strong>P<strong>at</strong>hology</strong> 2007; 20: S3


Chronic viral hep<strong>at</strong>itis<br />

• Hep<strong>at</strong>itis rel<strong>at</strong>ed changes<br />

e.g. Large cell change, HDV<br />

• Something else going on?<br />

Modern <strong>P<strong>at</strong>hology</strong> 2007; 20: S3


Large cell change<br />

• A focus <strong>of</strong> large cell change is defined as:<br />

a group <strong>of</strong> hep<strong>at</strong>ocytes with nuclear and<br />

cellular enlargement, normal N:C, nuclear<br />

pleomorphism, multinucle<strong>at</strong>ion, nuclear<br />

pseudoinclusions and prominent nucleoli<br />

Liver Intern<strong>at</strong>ional 2005; 25: 16


Large cell change<br />

• A marker for developing HCC (reactive) r<strong>at</strong>her<br />

than premalignant condition (dysplastic)<br />

Hep<strong>at</strong>ology 1996; 23: 1112<br />

but …<br />

Hep<strong>at</strong>ology 2009; 50: 752


Large cell change (or is it dysplasia?)


HDV


Drug reaction


? Something else going on<br />

• <strong>F<strong>at</strong>ty</strong> <strong>liver</strong> <strong>disease</strong><br />

ste<strong>at</strong>ohep<strong>at</strong>itis in 5% <strong>of</strong> <strong>liver</strong> biopsies <strong>of</strong><br />

p<strong>at</strong>ients with chronic <strong>liver</strong> <strong>disease</strong><br />

Mod P<strong>at</strong>hol 2003; 16: 49<br />

• Iron overload<br />

In p<strong>at</strong>ients with HCV: stainable iron was<br />

detected in 16%, grade 2 and 3 iron in 7%.<br />

J Gastroenterol Hep<strong>at</strong>ol 2005; 20: 243


<strong>F<strong>at</strong>ty</strong> change associ<strong>at</strong>ed with<br />

HCV genotype 3


<strong>F<strong>at</strong>ty</strong> <strong>liver</strong> <strong>disease</strong><br />

• How severe is <strong>the</strong> f<strong>at</strong>ty change?<br />

• Is <strong>the</strong>re a f<strong>at</strong>ty <strong>liver</strong> hep<strong>at</strong>itis?


<strong>F<strong>at</strong>ty</strong> <strong>liver</strong> <strong>disease</strong><br />

• How severe is <strong>the</strong> f<strong>at</strong>ty change?<br />

Ignore less than 5%<br />

Mild 5-33%<br />

Moder<strong>at</strong>e 34-66%<br />

Severe 67-100%<br />

Hep<strong>at</strong>ology 2005; 41: 1313


<strong>F<strong>at</strong>ty</strong> <strong>liver</strong> <strong>disease</strong><br />

• Is <strong>the</strong>re a f<strong>at</strong>ty <strong>liver</strong> hep<strong>at</strong>itis?<br />

Ballooning and inflamm<strong>at</strong>ion<br />

• Is <strong>the</strong>re fibrosis?<br />

Clin Liver Dis 2009; 13: 533


<strong>F<strong>at</strong>ty</strong> change: Portal tract fibrosis


Histology <strong>of</strong> NASH<br />

NAFLD Activity Score is <strong>the</strong> unweighted sum <strong>of</strong>:<br />

1. ste<strong>at</strong>osis (0-3)<br />

2. hep<strong>at</strong>ocellular ballooning (0-2)<br />

3. lobular inflamm<strong>at</strong>ion (0-2)<br />

NAS>5 “NASH”<br />

NAS


Iron overload<br />

• Wh<strong>at</strong> is <strong>the</strong> p<strong>at</strong>tern if iron overload?<br />

• Grade <strong>the</strong> degree <strong>of</strong> iron overload<br />

• Assess fibrosis<br />

• ? Send tissue for biochemical iron<br />

measurement<br />

American Journal <strong>of</strong> Gastroenterology 2000;<br />

95: 1788


Wh<strong>at</strong> is <strong>the</strong> p<strong>at</strong>tern <strong>of</strong> iron<br />

overload?<br />

• Parenchymal<br />

• Macrophage


Parenchymal iron:<br />

Simple Scoring System<br />

Grade Histological Fe<strong>at</strong>ures<br />

0 No iron present<br />

1 Iron seen in periportal hep<strong>at</strong>ocytes<br />

2 Iron seen in periportal and midzonal<br />

hep<strong>at</strong>ocytes<br />

3 Iron seen in all zones with a gradient from<br />

<strong>the</strong> periportal to <strong>the</strong> perivenular zones<br />

4 Iron seen in all zones with no gradient<br />

from <strong>the</strong> periportal to <strong>the</strong> perivenular<br />

zones


“We also know <strong>the</strong>re are known<br />

unknowns; th<strong>at</strong> is to say we know<br />

<strong>the</strong>re are some things we do not<br />

know.”


Clinician suspects <strong>the</strong> diagnosis<br />

and wants your help<br />

Examples:<br />

1. Autoimmune hep<strong>at</strong>itis<br />

2. Drug reaction<br />

3. Wilson’s <strong>disease</strong>


Autoimmune hep<strong>at</strong>itis<br />

• Help in making <strong>the</strong> diagnosis<br />

• Help in assessing <strong>the</strong> response to tre<strong>at</strong>ment


Revised AIH scoring system<br />

proposed by <strong>the</strong> IAIHG<br />

• Liver histology<br />

Interface hep<strong>at</strong>itis +3<br />

Lymphoplasmacytic infiltr<strong>at</strong>e +1<br />

Rosetting <strong>of</strong> <strong>liver</strong> cells +1<br />

None <strong>of</strong> <strong>the</strong> above -5<br />

Biliary changes -3<br />

O<strong>the</strong>r changes -3


Simplified histological criteria for<br />

• “Typical”<br />

1. Interface hep<strong>at</strong>itis<br />

<strong>the</strong> diagnosis <strong>of</strong> AIH<br />

2. lymphocytic / lymphoplasmacytic infiltr<strong>at</strong>es in portal tracts<br />

and extending into <strong>the</strong> lobule<br />

3. rosetting <strong>of</strong> <strong>liver</strong> cells<br />

• “Comp<strong>at</strong>ible" a chronic hep<strong>at</strong>itis with lymphocytic<br />

infiltr<strong>at</strong>ion without all <strong>the</strong> above fe<strong>at</strong>ures<br />

• “Atypical" for AIH when showing signs <strong>of</strong> ano<strong>the</strong>r diagnosis.<br />

Am J Gastroenterol advance online public<strong>at</strong>ion<br />

3 November 2009; doi: 10.1038/ajg.2009.616


Autoimmune Hep<strong>at</strong>itis


Autoimmune Hep<strong>at</strong>itis


AIH: Tre<strong>at</strong>ment failure<br />

• Its occurrence justifies clinical reassessment to exclude<br />

noncompliance with <strong>the</strong>rapy, alcohol consumption, or drug<br />

toxicity.<br />

• Labor<strong>at</strong>ory studies to exclude a superimposed viral infection<br />

or a transition st<strong>at</strong>e to PBC or PSC, and <strong>liver</strong> tissue is<br />

examined to reconfirm <strong>the</strong> original diagnosis and to assess<br />

altern<strong>at</strong>ive possibilities, including f<strong>at</strong>ty infiltr<strong>at</strong>ion, PBC, or<br />

PSC.<br />

Hep<strong>at</strong>ology 2007; 46: 1138


• Remission:<br />

Response to Tre<strong>at</strong>ment in<br />

Autoimmune Hep<strong>at</strong>itis<br />

Normal or minimal histological activity<br />

• Incomplete response<br />

Improved but more than minimal histological<br />

activity<br />

• Failure<br />

Worsening histological activity


Drug reaction


Drug reaction<br />

• “Any kind <strong>of</strong> <strong>liver</strong> <strong>disease</strong> can be caused by a<br />

drug”<br />

• Histological fe<strong>at</strong>ures suggesting a drug<br />

reaction:<br />

Eosinophils, plasma cells, granulomas, sharply<br />

demarc<strong>at</strong>ed necrosis, cholest<strong>at</strong>ic hep<strong>at</strong>itis<br />

J Clin P<strong>at</strong>hol 2009; 62:481


Drug reaction


Drug reaction


Wilson’s <strong>disease</strong>


Wilson’s <strong>disease</strong>


Wilson’s Disease<br />

Demonstr<strong>at</strong>ion <strong>of</strong> copper<br />

1. stains for Cu associ<strong>at</strong>ed protein: orcein<br />

2. stains for Cu: rhodamine, rubeanic acid<br />

but:<br />

1. ease <strong>of</strong> demonstr<strong>at</strong>ing copper varies with<br />

<strong>the</strong> stage <strong>of</strong> <strong>the</strong> <strong>disease</strong><br />

2. can be due to chronic cholest<strong>at</strong>ic <strong>liver</strong><br />

<strong>disease</strong>s


Wilson's <strong>disease</strong>:<br />

Diagnostic Criteria<br />

• Low serum caeruloplasmin levels<br />

• Kayser - Fleischer rings<br />

• High <strong>liver</strong> Cu levels > 250 micrograms/g dry weight<br />

• High 24 hr urinary copper levels<br />

• Radioisotope copper studies which assesses <strong>the</strong><br />

ability to incorpor<strong>at</strong>e copper into caeruloplasmin<br />

N<strong>at</strong>ure Clinical Practice Neurology 2006: 2;482-493


“But <strong>the</strong>re are also unknown<br />

unknowns -- <strong>the</strong> ones we don't<br />

know we don't know."


The clinician doesn't even suspect <strong>the</strong><br />

diagnosis<br />

• Examples:<br />

1. Granulomas<br />

2. Disappearing bile ducts


Granulomas<br />

• 2-10% <strong>of</strong> all <strong>liver</strong> biopsies<br />

• 1/3 have no known cause<br />

• Classific<strong>at</strong>ion<br />

Adv An<strong>at</strong> P<strong>at</strong>hol 2008; 15: 309


You can see <strong>the</strong> cause<br />

• Mycobacterial infection<br />

• Schistosomiasis


You can have an educ<strong>at</strong>ed guess<br />

• Sarcoid<br />

• PBC


Clinician (and P<strong>at</strong>hologist) does not<br />

suspect <strong>the</strong> diagnosis<br />

• Example:<br />

Disappearing bile ducts


Causes <strong>of</strong> Disappearing bile ducts<br />

• PBC (and its variants)<br />

• PSC<br />

• Drugs and Toxins<br />

• Chronic transplant rejection<br />

• Graft Vs. Host<br />

• Hodgkin’s Disease, Histiocytosis X<br />

• Sarcoid<br />

• Paucity <strong>of</strong> interlobular bile ducts<br />

• Idiop<strong>at</strong>hic


Biliary tract <strong>disease</strong>


Biliary tract <strong>disease</strong>: Orcein stain


Biliary tract <strong>disease</strong>: CK7


Wh<strong>at</strong> clinical inform<strong>at</strong>ion does <strong>the</strong><br />

p<strong>at</strong>hologist need?


Wh<strong>at</strong> clinical inform<strong>at</strong>ion does <strong>the</strong><br />

p<strong>at</strong>hologist need?<br />

• A decent clinical history!


Clinical inform<strong>at</strong>ion<br />

• Look <strong>at</strong> <strong>the</strong> biopsy and write <strong>the</strong> description<br />

without knowing any clinical inform<strong>at</strong>ion<br />

• Only write <strong>the</strong> conclusion when you have <strong>the</strong><br />

inform<strong>at</strong>ion


Biopsy Diagnosis <strong>of</strong> Liver Disease<br />

Daniel Snover<br />

• Dedic<strong>at</strong>ed to<br />

“<strong>the</strong> multitude <strong>of</strong> p<strong>at</strong>ients with abnormal<br />

LFTs”


Proposed classific<strong>at</strong>ion <strong>of</strong> <strong>liver</strong><br />

request forms


Inadequ<strong>at</strong>e <strong>liver</strong><br />

request form


Misleading <strong>liver</strong> request form<br />

• “HCV Cirrhosis”


“HCV Cirrhosis”


Surreal <strong>liver</strong> request form<br />

“Nodule left knee, 4cms, mobile<br />

? Ganglion”


Adequ<strong>at</strong>e <strong>liver</strong> request form


Honest request form

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!